Checking metabolic health in young children with congenital hypothyroidism
Observes metabolic risk in children aged 5 to 12 with congenital hypothyroidism.
Key facts
- Who runs it
- Buzzi Children's Hospital
- Where
- Milan, ItalySee the site
- Trial code
- Registry title
- Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism
- Status
- Not yet recruiting
- People taking part
- 170 people, planned
- Started
- Sept 2025
- Planned end
- Oct 2026
- Type of study
- Observational, 3 groups
- Treatments tested
- prospective observational study (clinical, hormonal and auxological data)
- Record updated
- 17 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for prepubertal children aged 5 to 12 years with permanent congenital hypothyroidism. It checks their risk of metabolic syndrome.
- Age
- 5 to 12 years
- Sex
- All sexes
- Disease stage
- Permanent congenital hypothyroidism. Pubertal stage Tanner 1.
Main reasons for not taking part
- Younger than 5 years
- Pubertal stage Tanner 2-5
- Transient congenital hypothyroidism
- Other types of hypothyroidism
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Pubertal stage Tanner 1
- Permanent congenital hypothyroidism
- All ethnic groups
- Informed consent signature
Who cannot take part
- Age< 5 years
- Pubertal stage Tanner 2-5
- Transient congenital hypothyroidism or other type of hypothyroidism
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 5 and 12 years old?
Where in Italy
- Buzzi Children's HospitalMilan, ItalyContact: Valeria Calcaterra, Prof, MDNo longer taking part
About the trial
What the trial wants to find out
We propose a multicenter prospective study to define the prevalence and severity score of metabolic syndrome in a prepubertal pediatric cohort with congenital hypothyroidism, compared to a healthy and normal-weight pediatric population. These data will help to define whether hypothyroidism can be considered a risk factor for the metabolic health of the pediatric population. The possible identification of an at-risk metabolic profile will provide useful information to optimize the diagnostic and monitoring pathway for affected children.
The 3 groups in the trial
- Permanent congenital hypothyroidism
170 patients in prepubertal age.
Treatment: prospective observational study (clinical, hormonal and auxological data)
- Healthy childrens normal weight
170 childrens in prepubertal age.
Treatment: prospective observational study (clinical, hormonal and auxological data)
- Healthy childrens overweight/obese
170 patients in prepubertal age
Treatment: prospective observational study (clinical, hormonal and auxological data)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Metabolic Risk Assessment in Prepubertal Children With Congenital Hypothyroidism (IpoMet)
- Plain-language title
- Checking metabolic health in young children with congenital hypothyroidismGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07126353, who can take part
- Record updated
- 17 August 2025